Is a complete PLRX research report available?

No complete published report is available for Pliant Therapeutics, Inc. (PLRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · USD

$0.86

+0.00 (+0.2%)· Recorded snapshot

Market cap	53.2M
Net income (ttm)	-92.3M
EPS (ttm)	-$1.50
Shares out	61.9M
Volume	114,254
Beta	1.28

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -92.3M
EPS (ttm): -$1.50
Market cap: 53.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Metric	Value
Amount currency	USD
CIK code	0001746473
Company name	Pliant Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	729139105
Earnings date	2026-11-09
Earnings time	amc
Employees	49
Employees change	-122
Employees growth	-71.35%
Enterprise value	$-76.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Biotechnology
IPO date	2020-06-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US7291391057
Last 10-K release date	2026-03-11
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$53.2M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$0.86
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	PLRX
U.S. state	California
Website	https://pliantrx.com

Metric

Value

Amount currency

USD

CIK code

0001746473

Company name

Pliant Therapeutics, Inc.

Country

United States

Country code

CUSIP number

729139105

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

-122

Employees growth

-71.35%

Enterprise value

$-76.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

Industry

Biotechnology

IPO date

2020-06-03

Is primary listing

Yes

Is SPAC

ISIN number

US7291391057

Last 10-K release date

2026-03-11

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$53.2M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$0.86

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

PLRX

U.S. state

California

Website

https://pliantrx.com

Metric	Value
Earnings yield	-174.37%
FCF / EV yield	94.27%
FCF yield	-130.91%
P/B ratio	0.36x
Price / tangible book value	0.37x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-174.37%

FCF / EV yield

94.27%

FCF yield

-130.91%

P/B ratio

0.36x

Price / tangible book value

0.37x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Profit per employee	$-1.9M
ROA	-23.27%
ROA (5Y)	-27.93%
ROCE	-52.58%
ROE	-50.29%
ROE (5Y)	-49.02%
ROIC	-24.99%

Metric

Value

Profit per employee

$-1.9M

ROA

-23.27%

ROA (5Y)

-27.93%

ROCE

-52.58%

ROE

-50.29%

ROE (5Y)

-49.02%

ROIC

-24.99%

Metric	Value
EPS growth quarters	5
EPS growth years	1
Net income growth quarters	5
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$1.3M
EBIT	$-91.2M
EBITDA	$-89.9M
EPS	$-1.50
FCF per share	$-1.14
Financing cash flow	$-32.1M
Free cash flow	$-70.9M
Free cash flow minus SBC	$-90.3M
Investing cash flow	$41.1M
Net borrowing	$-32.3M
Net cash flow	$-61.9M
Net income	$-92.3M
Operating cash flow minus SBC	$-90.3M
Operating income	$-91.2M
Stock-based compensation	$19.4M

Metric

Value

Capital expenditures

Depreciation and amortization

$1.3M

EBIT

$-91.2M

EBITDA

$-89.9M

EPS

$-1.50

FCF per share

$-1.14

Financing cash flow

$-32.1M

Free cash flow

$-70.9M

Free cash flow minus SBC

$-90.3M

Investing cash flow

$41.1M

Net borrowing

$-32.3M

Net cash flow

$-61.9M

Net income

$-92.3M

Operating cash flow minus SBC

$-90.3M

Operating income

$-91.2M

Stock-based compensation

$19.4M

Metric	Value
Book value per share	$2.37
Debt / equity	0.2
Interest coverage	-95.88
Long-term assets	$26.7M
Long-term liabilities	$26.5M
Net cash (debt)	$129.4M
Net cash / market cap	238.87%
Net cash growth	-36.12%
Net debt / equity	-0.88
Piotroski F-Score	1
Property, plant and equipment	$24.7M
Shareholders' equity	$146.9M
Tangible book value	$146.9M
Tangible book value per share	$2.37
Total assets	$189.9M
Total cash	$158.1M
Total debt	$28.7M
Total liabilities	$43M
WACC	8.28%

Metric

Value

Book value per share

$2.37

Debt / equity

0.2

Interest coverage

-95.88

Long-term assets

$26.7M

Long-term liabilities

$26.5M

Net cash (debt)

$129.4M

Net cash / market cap

238.87%

Net cash growth

-36.12%

Net debt / equity

-0.88

Piotroski F-Score

Property, plant and equipment

$24.7M

Shareholders' equity

$146.9M

Tangible book value

$146.9M

Tangible book value per share

$2.37

Total assets

$189.9M

Total cash

$158.1M

Total debt

$28.7M

Total liabilities

$43M

WACC

8.28%

Metric	Value
Current assets	$163.1M
Current liabilities	$16.5M
Current ratio	9.9
Net working capital	$-9.2M
Quick ratio	9.64
Working capital	$146.7M

Metric

Value

Current assets

$163.1M

Current liabilities

$16.5M

Current ratio

9.9

Net working capital

$-9.2M

Quick ratio

9.64

Working capital

$146.7M

Metric	Value
Buyback yield / dilution	-0.98%
Dividend yield	0%
Shareholder yield	-0.98%

Metric

Value

Buyback yield / dilution

-0.98%

Dividend yield

Shareholder yield

-0.98%

Metric	Value
150-day SMA	$1.13
1D price change	0.18%
1M price change	-19.02%
1M total return	-19.02%
1W price change	-4.15%
1W total return	-4.15%
1Y price change	-51.41%
1Y return CAGR	-51.44%
1Y total return	-51.41%
20-day SMA	$0.94
200-day SMA	$1.17
3M price change	-19.02%
3M total return	-19.02%
3Y price change	-93.47%
3Y return CAGR	-59.73%
3Y total return	-93.47%
50-day SMA	$1.06
50-day SMA vs 200-day SMA	50under200
52-week high	$1.83
52-week high date	2025-10-28
52-week low	$0.83
52-week low date	2026-10-27
5Y price change	-94.44%
5Y return CAGR	-43.9%
5Y total return	-94.44%
6M price change	-27.72%
6M total return	-27.72%
All-time high	$43.92
All-time high date	2021-02-25
All-time low	$0.83
All-time low date	2026-10-27
Average true range (ATR)	$0.05
Average volume	400.2K
Beta (1Y)	1.19
Beta (2Y)	1.26
Beta (5Y)	1.28
Change from 52-week high	-53.08%
Change from 52-week low	3.41%
Change from all-time high	-98.01%
Change from all-time low	5.33%
Change from open	1.61%
Day's gap	-1.41%
Dollar volume	$98,098
High price	$0.86
Low price	$0.85
Monthly RSI	31.42
Open price	$0.85
Position in 52-week range	100%
Previous close	$0.86
Price vs 150-day SMA	-22.88%
Price vs 20-day SMA	-7.32%
Price vs 200-day SMA	-25%
Price vs 50-day SMA	-17.1%
Relative volume	0.29
Return from IPO open	-96.5%
Return from IPO price	-94.53%
RSI	35.99
Sharpe ratio	-1.3
Sharpe ratio (3Y)	-0.65
Sharpe ratio (5Y)	-0.16
Sortino ratio	-1.62
Sortino ratio (3Y)	-0.72
Sortino ratio (5Y)	-0.21
Volume	114.3K
Weekly RSI	31.58
YTD price change	-28.32%
YTD total return	-28.32%

Metric

Value

150-day SMA

$1.13

1D price change

0.18%

1M price change

-19.02%

1M total return

-19.02%

1W price change

-4.15%

1W total return

-4.15%

1Y price change

-51.41%

1Y return CAGR

-51.44%

1Y total return

-51.41%

20-day SMA

$0.94

200-day SMA

$1.17

3M price change

-19.02%

3M total return

-19.02%

3Y price change

-93.47%

3Y return CAGR

-59.73%

3Y total return

-93.47%

50-day SMA

$1.06

50-day SMA vs 200-day SMA

50under200

52-week high

$1.83

52-week high date

2025-10-28

52-week low

$0.83

52-week low date

2026-10-27

5Y price change

-94.44%

5Y return CAGR

-43.9%

5Y total return

-94.44%

6M price change

-27.72%

6M total return

-27.72%

All-time high

$43.92

All-time high date

2021-02-25

All-time low

$0.83

All-time low date

2026-10-27

Average true range (ATR)

$0.05

Average volume

400.2K

Beta (1Y)

1.19

Beta (2Y)

1.26

Beta (5Y)

1.28

Change from 52-week high

-53.08%

Change from 52-week low

3.41%

Change from all-time high

-98.01%

Change from all-time low

5.33%

Change from open

1.61%

Day's gap

-1.41%

Dollar volume

$98,098

High price

$0.86

Low price

$0.85

Monthly RSI

31.42

Open price

$0.85

Position in 52-week range

100%

Previous close

$0.86

Price vs 150-day SMA

-22.88%

Price vs 20-day SMA

-7.32%

Price vs 200-day SMA

-25%

Price vs 50-day SMA

-17.1%

Relative volume

0.29

Return from IPO open

-96.5%

Return from IPO price

-94.53%

RSI

35.99

Sharpe ratio

-1.3

Sharpe ratio (3Y)

-0.65

Sharpe ratio (5Y)

-0.16

Sortino ratio

-1.62

Sortino ratio (3Y)

-0.72

Sortino ratio (5Y)

-0.21

Volume

114.3K

Weekly RSI

31.58

YTD price change

-28.32%

YTD total return

-28.32%

Metric	Value
Float	55M
Float percentage	88.88%
Shares change (QoQ)	0.19%
Shares change (YoY)	0.98%
Shares held by insiders	2.23%
Shares held by institutions	69.4%
Shares outstanding	61.9M
Short % of float	7.72%
Short % of shares	6.86%
Short ratio	10.8 days

Metric

Value

Float

55M

Float percentage

88.88%

Shares change (QoQ)

0.19%

Shares change (YoY)

0.98%

Shares held by insiders

2.23%

Shares held by institutions

69.4%

Shares outstanding

61.9M

Short % of float

7.72%

Short % of shares

6.86%

Short ratio

10.8 days

Pliant Therapeutics, Inc. (PLRX)

Price

Financial snapshot

Fair-value bridge

Latest news · PLRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PLRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PLRX

Frequently asked questions